A detailed history of Handelsinvest Investeringsforvaltning transactions in Alkermes Plc. stock. As of the latest transaction made, Handelsinvest Investeringsforvaltning holds 6,284 shares of ALKS stock, worth $186,320. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,284
Previous 9,546 34.17%
Holding current value
$186,320
Previous $265,000 35.85%
% of portfolio
0.08%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$26.4 - $32.56 $86,116 - $106,210
-3,262 Reduced 34.17%
6,284 $170,000
Q4 2023

Jan 11, 2024

BUY
$23.37 - $28.68 $223,090 - $273,779
9,546 New
9,546 $265,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Handelsinvest Investeringsforvaltning Portfolio

Follow Handelsinvest Investeringsforvaltning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

News

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.